ABBV vs SENS

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Senseonics (SENS) continues to present an extremely high-risk, high-reward profile with the path to 10x potential remaining significantly challenging. While the Eversense long-term implantable CGM offers a unique proposition in the vast diabetes market, previous commercialization struggles and persistent cash burn are still critical concerns. The market cap has slightly adjusted from the previous ...